1. Home
  2. GCDT vs ADIL Comparison

GCDT vs ADIL Comparison

Compare GCDT & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

N/A

Current Price

$0.61

Market Cap

7.2M

Sector

Industrials

ML Signal

N/A

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$2.79

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCDT
ADIL
Founded
1992
2010
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
6.4M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GCDT
ADIL
Price
$0.61
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$37.50
AVG Volume (30 Days)
323.6K
1.2M
Earning Date
05-16-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.13
52 Week High
$5.32
$5.17

Technical Indicators

Market Signals
Indicator
GCDT
ADIL
Relative Strength Index (RSI) 46.45 57.40
Support Level $0.55 $2.22
Resistance Level $1.47 $3.67
Average True Range (ATR) 0.06 0.22
MACD 0.01 -0.01
Stochastic Oscillator 47.95 69.45

Price Performance

Historical Comparison
GCDT
ADIL

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: